KYMR
Kymera Therapeutics Inc
115.50$
-5.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +163.8% | +317.5% | +24.4% | -0.5% | -4.5% | +69.9% | +78.2% | |
| – | +122.2% | +225.6% | +49.3% | -7.1% | -3.4% | +25.9% | +70.7% | |
| – | +84.2% | -59.2% | +54.7% | +42.6% | +60.8% | +9.4% | +196.9% | |
| – | +122.9% | +222.1% | +49.4% | -8.0% | -7.9% | +30.4% | +73.6% | |
| – | +93.9% | +399.3% | -90.6% | +1,779.3% | +639.5% | -95.0% | – | |
| – | – | – | – | – | – | – | – | |
| – | +885.0% | -6.3% | -42.6% | +12.2% | – | – | – | |
| – | +142.9% | +6.4% | -28.0% | -22.8% | +60.0% | -21.2% | +14.6% | |
| – | +637.6% | +220.0% | -16.3% | -22.9% | +20.1% | -20.9% | +22.8% | |
| – | +1,018.2% | -3.4% | +10.4% | +9.6% | +60.9% | +106.7% | +4.9% | |
| – | +59.3% | +33.3% | -8.3% | +8.2% | +63.2% | -15.3% | -33.0% | |
| – | – | – | +61.9% | +6.6% | -19.4% | +111.6% | +89.0% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.1% | +7.7% | +12.4% | +8.2% | +28.6% | +12.5% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.